Skip to content

Hybrid-FES Exercise to Prevent Cardiovascular Declines in Acute SCI

Hybrid-FES Exercise to Prevent Cardiovascular Declines in Acute SCI

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02139436
Enrollment
68
Registered
2014-05-15
Start date
2013-12-31
Completion date
2021-03-01
Last updated
2022-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injury

Brief summary

Each year, 11,000 people suffer a spinal cord injury (SCI) in the U.S. Within the first year, there are profound declines in physiologic function, forming the underlying substrate for future cardiovascular disease . In fact, acquired cardiovascular disease is an increasingly recognized consequence of SCI and is the leading cause of death in SCI. Though incompletely understood, the almost 10-fold prevalence of cardiovascular disease results in part from profound physiologic 'detraining' resulting from motor impairment and immobility. Currently, effective interventions preventing acute declines that lead to cardiovascular compromise and increased risk in SCI are lacking - exercise therapy for those with SCI is challenging and when employed, is typically limited to the upper body. Recently, the investigators refined a unique form of exercise for those with SCI that specifically mirrors exercise performed by those without SCI. Functional Electrical Stimulation (FES) Row Training (RT) couples volitional arm and electrically controlled leg exercise, resulting in a hemodynamic profile that produces the beneficial cardiac loading conditions of large muscle mass exercise. As such, FES-RT may be a safe and effective way to attenuate cardiovascular declines following SCI. The investigators aims are to test the overall hypotheses that FES-RT will: 1) mitigate against increased visceral adiposity and reduced insulin sensitivity, 2) prevent worsening lipid profile and compromised baroreflex function, and 3) counter ventricular wall thickening and declining ventricular function occurring with acute SCI, and that these effects will be greater than that observed with an arms-only exercise group. Changes with FES-RT will be compared to a time (wait-list) control and to arms-only-RT. Individuals with an SCI within the last 3-6 months will be randomized to FES-RT, to a time control, or arms-only-RT. Measures will be made at baseline and 6 months. The investigators work will provide results that clearly delineate potential health benefits of FES-RT, and if FES-RT is effective in a majority of those with SCI, its application, implementation, and integration could be easily replicated.

Detailed description

We will enroll approximately 60 individuals within three to six months post SCI to obtain data on 50 individuals. One-half of the subjects (N=25) will be randomized to immediately enroll in 6 months of FES-RT. One third (N=18) will be randomized to a wait-list to provide time control data from baseline to 6 months. A wait-list control group is routine in exercise studies because most volunteers are interested in participating in an exercise program. Hence, time controls are difficult to capture since many of those randomized to receive no exercise either drop from the study entirely, or end up pursuing some form of exercise on their own. Therefore, a vehicle for enrollment of a time control group that is acceptable to most volunteers is a wait-list. Therefore, a six month time control will provide data on expected declines and then subjects will be randomized to six months exercise. Training Protocols for Each Study Group 1. FES-RT GROUP Subjects will begin with short intervals of FES-RT interspersed with rest intervals and/or arms-only rowing intervals depending on fitness level and the response to the FES. A maximum FES-rowing test will be performed at baseline. This will be repeated after three months of training and training intensity will be adjusted to maintain the training stimulus at the same relative intensity. The goal is for each volunteer to achieve an exercise intensity of 75-85% maintained for a continuous 30 minutes performed three times each week. A maximum FES-rowing test will be performed at the end of the six months of FES-RT to determine increases in fitness. 2. ARMS-ONLY-RT GROUP Training sessions will be 3 times per week for 26 weeks. To parallel the FES-RT, the initial training sessions will also consist of 6 sets of arms-only rowing for five minutes at 60% of VO2peak with a work-to-rest ratio of 2:1 and progress over the six months to an exercise intensity of 75-85% maintained for 30 minutes performed three times each week. A maximum arms-only rowing test will be performed at baseline. This will be repeated after three months of training and training intensity will be adjusted to maintain the training stimulus at the same relative intensity. A maximum arms-only rowing test will be performed at the end of the six months of training to determine increases in fitness. 3. WAIT-LIST GROUP The wait list group will not participate in any training for 6 months. A maximum arms-only rowing test will be performed immediately after enrollment, after initial familiarization with arms-only-RT equipment (usually 2-3 sessions) and will be repeated after 3 and 6 months

Interventions

OTHERFES-row-training
OTHERArms-only-row training

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Spaulding Rehabilitation Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Three intervention groups (Control, AO-Row, and FES-RT) run in parallel

Eligibility

Sex/Gender
ALL
Age
20 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Spinal cord injured outpatients aged 18-40 * medically stable * body mass index 18.5-30.0 * 3-12 months post SCI * ASIA scale A, B or C at neurological level C5-T12 * able to follow directions * leg muscles responsive to FES

Exclusion criteria

* hypertension * significant arrhythmias * coronary artery disease * diabetes * renal disease * cancer * epilepsy * current use of cardioactive medications * current grade 2 or greater pressure ulcers at relevant contact sites * other neurological disease * peripheral nerve compressions or rotator cuff tears that limit ability to row * history of bleeding disorder

Design outcomes

Primary

MeasureTime frameDescription
Change From Baseline in Exercise Capacity at 6 MonthsBaseline and 6 monthsVolunteers will perform an incremental exercise test of FES- or arms-only rowing to determine maximal oxygen uptake.
Change From Baseline in Visceral Adiposity at 6 MonthsBaseline, 6 monthsWe will use a 5th generation General Electric Healthcare dual x-ray absorptiometry(DXA) scanner for regional fat measurements, the DXA software can be used to define standard regions that will allow comparability of measurements throughout the study.
Change From Baseline in Myocardial Structure at 6 Months.Baseline and 6 monthsEchocardiography was performed using a commercially available system(Vivid-1, General Electric Healthcare)to obtain measures of left ventricular wall thickness and left ventricular diastolic function.
Change From Baseline in Insulin Sensitivity at 6 Months.Baseline and 6 monthsBlood will be taken via standard venipuncture to measure the homeostasis model assessment of insulin resistance (HOMA-IR). HOMA-IR is a measure of insulin resistance/sensitivity calculated by multiplying fasting insulin (μU/mL) by fasting glucose (mg/dL) and divided by a constant (405). A higher value indicates higher insulin resistance.
Change From Baseline in Blood Lipids at 6 MonthsBaseline and 6 monthsBlood will be taken via standard venipuncture to measure: total cholesterol.

Countries

United States

Participant flow

Participants by arm

ArmCount
FES-row-training
Subjects will perform 6 months of FES-row-training. FES-row-training
41
Wait-list Time Control
Subjects perform 6 months of their standard of care Time Control
14
Arms-only-row-training
Subjects will perform 6 months of arms-only row training Arms-only-row training
13
Total68

Baseline characteristics

CharacteristicWait-list Time ControlArms-only-row-trainingTotalFES-row-training
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
14 Participants13 Participants68 Participants41 Participants
Age, Continuous28 years
STANDARD_DEVIATION 6
28 years
STANDARD_DEVIATION 6
28 years
STANDARD_DEVIATION 6
28 years
STANDARD_DEVIATION 5
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants0 Participants3 Participants2 Participants
Race (NIH/OMB)
Black or African American
1 Participants3 Participants7 Participants3 Participants
Race (NIH/OMB)
More than one race
1 Participants1 Participants4 Participants2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants1 Participants7 Participants6 Participants
Race (NIH/OMB)
White
11 Participants8 Participants47 Participants28 Participants
Region of Enrollment
United States
14 Participants13 Participants68 Participants41 Participants
Sex: Female, Male
Female
1 Participants1 Participants10 Participants8 Participants
Sex: Female, Male
Male
13 Participants12 Participants58 Participants33 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 410 / 140 / 13
other
Total, other adverse events
8 / 410 / 141 / 13
serious
Total, serious adverse events
0 / 411 / 141 / 13

Outcome results

Primary

Change From Baseline in Blood Lipids at 6 Months

Blood will be taken via standard venipuncture to measure: total cholesterol.

Time frame: Baseline and 6 months

Population: The reported results represent a sub-population of the total number of subjects who completed the study. Some subjects did not complete the 6 month blood draw. Therefore, the presented numbers represent reliable and unbiased data.

ArmMeasureGroupValue (MEAN)Dispersion
Waitlist ControlsChange From Baseline in Blood Lipids at 6 MonthsBaseline170 mg/dLStandard Error 8
Waitlist ControlsChange From Baseline in Blood Lipids at 6 Months6 Months171 mg/dLStandard Error 8
Arms OnlyChange From Baseline in Blood Lipids at 6 MonthsBaseline157 mg/dLStandard Error 9
Arms OnlyChange From Baseline in Blood Lipids at 6 Months6 Months141 mg/dLStandard Error 10
FES-RowingChange From Baseline in Blood Lipids at 6 MonthsBaseline158 mg/dLStandard Error 4
FES-RowingChange From Baseline in Blood Lipids at 6 Months6 Months149 mg/dLStandard Error 4
Primary

Change From Baseline in Exercise Capacity at 6 Months

Volunteers will perform an incremental exercise test of FES- or arms-only rowing to determine maximal oxygen uptake.

Time frame: Baseline and 6 months

Population: The reported results represent a sub-population of the total number of subjects who completed the study. Some subjects did not complete the 6 month VO2 or their results were removed due to quality control or not meeting the criteria for a good test. Therefore, the presented numbers represent reliable and unbiased data.

ArmMeasureGroupValue (MEAN)Dispersion
Waitlist ControlsChange From Baseline in Exercise Capacity at 6 MonthsBaseline14.6 ml/kg/minStandard Error 3.4
Waitlist ControlsChange From Baseline in Exercise Capacity at 6 Months6 Months13.9 ml/kg/minStandard Error 2.5
Arms OnlyChange From Baseline in Exercise Capacity at 6 MonthsBaseline18.5 ml/kg/minStandard Error 3.7
Arms OnlyChange From Baseline in Exercise Capacity at 6 Months6 Months18.2 ml/kg/minStandard Error 4.4
FES-RowingChange From Baseline in Exercise Capacity at 6 MonthsBaseline17.1 ml/kg/minStandard Error 1.2
FES-RowingChange From Baseline in Exercise Capacity at 6 Months6 Months18.9 ml/kg/minStandard Error 1.5
Primary

Change From Baseline in Insulin Sensitivity at 6 Months.

Blood will be taken via standard venipuncture to measure the homeostasis model assessment of insulin resistance (HOMA-IR). HOMA-IR is a measure of insulin resistance/sensitivity calculated by multiplying fasting insulin (μU/mL) by fasting glucose (mg/dL) and divided by a constant (405). A higher value indicates higher insulin resistance.

Time frame: Baseline and 6 months

Population: The reported results represent a sub-population of the total number of subjects who completed the study. Some subjects did not complete the 6 month blood draw. Therefore, the presented numbers represent reliable and unbiased data.

ArmMeasureGroupValue (MEAN)Dispersion
Waitlist ControlsChange From Baseline in Insulin Sensitivity at 6 Months.Baseline2.7 HOMA-IR IndexStandard Error 1.7
Waitlist ControlsChange From Baseline in Insulin Sensitivity at 6 Months.6 Months3.1 HOMA-IR IndexStandard Error 1.5
Arms OnlyChange From Baseline in Insulin Sensitivity at 6 Months.Baseline0.9 HOMA-IR IndexStandard Error 0.1
Arms OnlyChange From Baseline in Insulin Sensitivity at 6 Months.6 Months0.6 HOMA-IR IndexStandard Error 0.2
FES-RowingChange From Baseline in Insulin Sensitivity at 6 Months.Baseline1.4 HOMA-IR IndexStandard Error 0.5
FES-RowingChange From Baseline in Insulin Sensitivity at 6 Months.6 Months1.7 HOMA-IR IndexStandard Error 0.6
Primary

Change From Baseline in Myocardial Structure at 6 Months.

Echocardiography was performed using a commercially available system(Vivid-1, General Electric Healthcare)to obtain measures of left ventricular wall thickness and left ventricular diastolic function.

Time frame: Baseline and 6 months

Population: The reported results represent a sub-population of the total number of subjects who completed the study. Some subjects did not complete the 6 month echocardiography or their results were removed due to quality control or not meeting the criteria for a good test. Therefore, the presented numbers represent reliable and unbiased data.

ArmMeasureGroupValue (MEAN)Dispersion
Waitlist ControlsChange From Baseline in Myocardial Structure at 6 Months.Baseline136 gStandard Error 4
Waitlist ControlsChange From Baseline in Myocardial Structure at 6 Months.6 Months129 gStandard Error 8
Arms OnlyChange From Baseline in Myocardial Structure at 6 Months.Baseline149 gStandard Error 5
Arms OnlyChange From Baseline in Myocardial Structure at 6 Months.6 Months133 gStandard Error 4
FES-RowingChange From Baseline in Myocardial Structure at 6 Months.Baseline143 gStandard Error 2
FES-RowingChange From Baseline in Myocardial Structure at 6 Months.6 Months138 gStandard Error 4
Primary

Change From Baseline in Visceral Adiposity at 6 Months

We will use a 5th generation General Electric Healthcare dual x-ray absorptiometry(DXA) scanner for regional fat measurements, the DXA software can be used to define standard regions that will allow comparability of measurements throughout the study.

Time frame: Baseline, 6 months

Population: These are subgroups of the main study population. Exercise groups were combined.

ArmMeasureGroupValue (MEAN)Dispersion
Waitlist ControlsChange From Baseline in Visceral Adiposity at 6 MonthsBaseline13649 gStandard Error 1320
Waitlist ControlsChange From Baseline in Visceral Adiposity at 6 Months6-Months16057 gStandard Error 1952
Arms OnlyChange From Baseline in Visceral Adiposity at 6 Months6-Months11247 gStandard Error 1390
Arms OnlyChange From Baseline in Visceral Adiposity at 6 MonthsBaseline10503 gStandard Error 1235
FES-RowingChange From Baseline in Visceral Adiposity at 6 MonthsBaseline10945 gStandard Error 2310
FES-RowingChange From Baseline in Visceral Adiposity at 6 Months6-Months12197 gStandard Error 2492

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026